These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29948868)

  • 1. The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span.
    Rožman P
    Geroscience; 2018 Jun; 40(3):221-242. PubMed ID: 29948868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Could We Slow or Reverse the Human Aging Process and Extend the Healthy Life Span with Heterochronous Autologous Hematopoietic Stem Cell Transplantation.
    Rožman P
    Rejuvenation Res; 2020 Apr; 23(2):159-170. PubMed ID: 31203790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation.
    Lin RJ; Elias HK; van den Brink MRM
    Front Immunol; 2021; 12():674093. PubMed ID: 33953731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, the Ottawa Protocol.
    Puyade M; Brunet F; Carolina R; Fergusson N; Makedonov I; Freedman MS; Atkins H
    Curr Protoc; 2022 May; 2(5):e437. PubMed ID: 35594180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.
    Koç ON; Gerson SL; Cooper BW; Dyhouse SM; Haynesworth SE; Caplan AI; Lazarus HM
    J Clin Oncol; 2000 Jan; 18(2):307-16. PubMed ID: 10637244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.
    Makhani SS; Oza SP; Reich-Slotky R; Munshi PN; Biran N; Donato ML; Siegel DS; Vesole DH; Naam S; Rowley SD
    Transplant Cell Ther; 2022 Jun; 28(6):306.e1-306.e7. PubMed ID: 35248777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of hematopoietic stem cells for use in autologous transplantation.
    Devine H; Tierney DK; Schmit-Pokorny K; McDermott K
    Clin J Oncol Nurs; 2010 Apr; 14(2):212-22. PubMed ID: 20350895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A faster reconstitution of hematopoiesis after autologous transplantation of hematopoietic cells cryopreserved in 7.5% dimethyl sulfoxide if compared to 10% dimethyl sulfoxide containing medium.
    Mitrus I; Smagur A; Giebel S; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Sadus-Wojciechowska M; Tukiendorf A; Holowiecki J
    Cryobiology; 2013 Dec; 67(3):327-31. PubMed ID: 24125911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
    Abrahamsson SV; Angelini DF; Dubinsky AN; Morel E; Oh U; Jones JL; Carassiti D; Reynolds R; Salvetti M; Calabresi PA; Coles AJ; Battistini L; Martin R; Burt RK; Muraro PA
    Brain; 2013 Sep; 136(Pt 9):2888-903. PubMed ID: 23864273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Heterochronic Non-Myeloablative Bone Marrow Transplantation on the Immune System, Frailty, General Health, and Longevity of Aged Murine Recipients.
    Jazbec K; Jež M; Švajger U; Smrekar B; Miceska S; Rajčevič U; Justin M; Završnik J; Malovrh T; Švara T; Gombač M; Ramšak Ž; Rožman P
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging impairs long-term hematopoietic regeneration after autologous stem cell transplantation.
    Woolthuis CM; Mariani N; Verkaik-Schakel RN; Brouwers-Vos AZ; Schuringa JJ; Vellenga E; de Wolf JT; Huls G
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):865-71. PubMed ID: 24607555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technical aspects of autologous bone marrow transplantation].
    Handgretinger R; Klingebiel T; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and rejuvenation strategies for aged hematopoietic stem cells.
    Li X; Zeng X; Xu Y; Wang B; Zhao Y; Lai X; Qian P; Huang H
    J Hematol Oncol; 2020 Apr; 13(1):31. PubMed ID: 32252797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry.
    Bekadja MA; Boumendil A; Blaise D; Chevallier P; Peggs KS; Salles G; Giebel S; Marks R; Arcese W; Milpied N; Finel H; Gorin NC
    Cytotherapy; 2021 Jun; 23(6):483-487. PubMed ID: 33678598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.
    Slavin S; Nagler A; Aker M; Shapira MY; Cividalli G; Or R
    Rev Clin Exp Hematol; 2001 Jun; 5(2):135-46. PubMed ID: 11486652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation.
    Porrata LF
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
    Burt RK; Loh Y; Cohen B; Stefoski D; Balabanov R; Katsamakis G; Oyama Y; Russell EJ; Stern J; Muraro P; Rose J; Testori A; Bucha J; Jovanovic B; Milanetti F; Storek J; Voltarelli JC; Burns WH
    Lancet Neurol; 2009 Mar; 8(3):244-53. PubMed ID: 19186105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.